Table 1.

Epidemiological associations with PVL status

Characteristic	PVL positive (n = 141)	PVL negative (n = 148)	p-value
Age (median)	37	58	<0.001
Male	102 (72.3)	93 (62.8)	0.085
Indigenous	48 (34.0)	18 (12.2)	<0.001
Intravenous Drug Use	23 (16.3)	10 (6.8)	0.011
Haematological malignancy	0 (0)	6 (4.1)	0.016
Solid malignancy	2 (1.4)	14 (9.5)	0.003
Diabetes Mellitus	31 (22)	44 (29.7)	0.133
Immunosuppressive treatment	7 (5)	14 (9.5)	0.141
HIV positive	3 (2.1)	2 (1.4)	0.613
Pre-existing skin condition	4 (2.8)	4 (2.7)	0.945
Hospitalisation in the past year	50 (35.5)	92 (61.2)	<0.001
Long term care facility resident	2 (1.4)	22 (14.9)	<0.001
“Community acquired” infection	87 (61.7)	35 (23.6)	<0.001
“Healthcare associated” infection	46 (32.6)	78 (52.7)	<0.001
“Hospital acquired” infection	8 (5.7)	35 (23.6)	<0.001

Number (%).